KPAX 002 as a treatment for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome ( ME / CFS ) : a prospective , randomized trial
For type 2 diabetes , NICE guideline NG28 recommends considering GLP-1 agonists as an option when: Triple therapy with metformin and two other oral drugs is ineffective, not tolerated, or contraindicated The person has a BMI 35 kg/m (or 32.5 kg/m in people of South Asian or related ethnicity) and specific psychological or medical problems associated with obesity Insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities Treatment should be continued only if there is a beneficial metabolic response (HbA1c reduction of at least 11 mmol/mol [1.0%] and weight loss of at least 3% of initial body weight at 6 months)
NAC NAC contains an acetylated amino group
Potential Risks and Side Effects As with any medical treatment, there are potential risks and side effects associated with the use of Semaglutide and CO2 Fractional Laser
NAD+ Therapy: The Cellular Reboot Your Mitochondria Actually Need If youre tracking healthspan (quality of life years, not just longevity), NAD+ should be on your radar
The hormones role extends beyond just appetite regulation and food intake reduction
